0000000000428523

AUTHOR

Anne-sophie Lebre

0000-0002-7519-9822

showing 4 related works from this author

Clinical Utility of a Unique Genome-Wide DNA Methylation Signature for KMT2A-Related Syndrome

2022

Wiedemann–Steiner syndrome (WDSTS) is a Mendelian syndromic intellectual disability (ID) condition associated with hypertrichosis cubiti, short stature, and characteristic facies caused by pathogenic variants in the KMT2A gene. Clinical features can be inconclusive in mild and unusual WDSTS presentations with variable ID (mild to severe), facies (typical or not) and other associated malformations (bone, cerebral, renal, cardiac and ophthalmological anomalies). Interpretation and classification of rare KMT2A variants can be challenging. A genome-wide DNA methylation episignature for KMT2A-related syndrome could allow functional classification of variants and provide insights into the pathoph…

Wiedemann–Steiner syndromeQH301-705.5Intellectual disability[SDV.BC]Life Sciences [q-bio]/Cellular BiologyCatalysisInorganic ChemistryKMT2A geneNeurodevelopmental disorderGrowth DisorderAbnormalities Multiple[SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Biology (General)Physical and Theoretical ChemistryEpisignatureQD1-999[SDV.BC] Life Sciences [q-bio]/Cellular BiologyMolecular BiologySpectroscopyDNA methylationOrganic ChemistryNeurodevelopmental disordersCraniofacial AbnormalitieEpigeneticHypertrichosiGeneral MedicineFacieComputer Science Applications<i>KMT2A</i> geneChemistryepigenetics; DNA methylation; episignature; Wiedemann–Steiner syndrome; <i>KMT2A</i> gene; intellectual disability; neurodevelopmental disordersPhenotype[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]EpigeneticsHuman
researchProduct

Correction: The landscape of epilepsy-related GATOR1 variants

2019

International audience; The original version of this article contained an error in the spelling of the author Erik H. Niks, which was incorrectly given as Erik Niks. This has now been corrected in both the PDF and HTML versions of the article.

0303 health sciencesbusiness.industryPublished ErratumMEDLINEmedicine.diseasecomputer.software_genreSpelling03 medical and health sciencesEpilepsy0302 clinical medicine[SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human geneticsmedicineArtificial intelligencebusinessPsychologycomputer030217 neurology & neurosurgeryGenetics (clinical)Natural language processing030304 developmental biology
researchProduct

The landscape of epilepsy-related GATOR1 variants

2019

Purpose:\ud \ud To define the phenotypic and mutational spectrum of epilepsies related to DEPDC5, NPRL2 and NPRL3 genes encoding the GATOR1 complex, a negative regulator of the mTORC1 pathway.\ud \ud Methods:\ud \ud We analyzed clinical and genetic data of 73 novel probands (familial and sporadic) with epilepsy-related variants in GATOR1-encoding genes and proposed new guidelines for clinical interpretation of GATOR1 variants.\ud \ud Results:\ud \ud The GATOR1 seizure phenotype consisted mostly in focal seizures (e.g., hypermotor or frontal lobe seizures in 50%), with a mean age at onset of 4.4 years, often sleep-related and drug-resistant (54%), and associated with focal cortical dysplasia…

Male0301 basic medicineProbandDEPDC5SUDEP030105 genetics & heredityBioinformaticsLoss of Function Mutation/geneticsEpilepsyINDEL MutationLoss of Function MutationmTORC1 pathwayGenetics(clinical)ChildGenetics (clinical)Multiprotein Complexes/geneticsBrugada SyndromeDNA Copy Number VariationBrugada syndromeINDEL Mutation/geneticsGTPase-Activating ProteinsNPRL3SeizureDEPDC5PhenotypePedigree3. Good healthBrugada Syndrome/geneticsChild PreschoolFemaleHumanSignal TransductionDNA Copy Number VariationsAdolescentSeizures/complicationsMechanistic Target of Rapamycin Complex 1/geneticsDNA Copy Number Variations/geneticsMechanistic Target of Rapamycin Complex 1Tumor Suppressor Proteins/geneticsArticleFocal cortical dysplasia03 medical and health sciencesSeizuresGTPase-Activating Proteins/geneticsmedicineHumansGenetic Predisposition to DiseaseDEPDC5; Focal cortical dysplasia; Genetic focal epilepsy; mTORC1 pathway; SUDEPGenetic focal epilepsyEpilepsy/complicationsRepressor Proteins/geneticsEpilepsybusiness.industryGTPase-Activating ProteinTumor Suppressor ProteinsInfant NewbornCorrectionInfantRepressor ProteinCortical dysplasiamedicine.diseaseddc:616.8Repressor Proteins030104 developmental biologyFrontal lobe seizures[SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human geneticsMultiprotein ComplexesMultiprotein ComplexeSignal Transduction/geneticsHuman medicinebusiness
researchProduct

Genotype-first in a cohort of 95 fetuses with multiple congenital abnormalities: when exome sequencing reveals unexpected fetal phenotype-genotype co…

2020

PurposeMolecular diagnosis based on singleton exome sequencing (sES) is particularly challenging in fetuses with multiple congenital abnormalities (MCA). Indeed, some studies reveal a diagnostic yield of about 20%, far lower than in live birth individuals showing developmental abnormalities (30%), suggesting that standard analyses, based on the correlation between clinical hallmarks described in postnatal syndromic presentations and genotype, may underestimate the impact of the genetic variants identified in fetal analyses.MethodsWe performed sES in 95 fetuses with MCA. Blind to phenotype, we applied a genotype-first approach consisting of combined analyses based on variants annotation and …

Candidate genemedicine.medical_specialtyGenotype[SDV]Life Sciences [q-bio]BiologyCongenital AbnormalitiesCohort Studiescomplex traits03 medical and health sciencesFetusMolecular geneticsGenotypemedicineHumansAbnormalities MultipleExomeClinical significancegeneticsGeneGenetic Association StudiesGenetics (clinical)Exome sequencing030304 developmental biologyGenetics0303 health sciencesFetus030305 genetics & hereditySequence Analysis DNAPhenotype[SDV] Life Sciences [q-bio]molecular geneticsreproductive medicine
researchProduct